mTOR Pathway Substrates Present High Activation in Vascular Malformations and Significantly Decrease with Age.

There Is a Higher Expression of Activated p-4EBP1 in VMs than in LMs and a Higher Expression of S6K1 and 4EBP1 in Lymphatic Malformations There is a significant trend toward difference in expression of non-phosphorylated substrates in lymphatic and venous malformations.

also in 9,775 other papers